Physiology
Phototransduction
A single photon flips a molecular switch, closes ion channels, and tells the brain "light" by going dark
Phototransduction is the process by which a photoreceptor converts light into an electrical signal. A single photon isomerizes 11-cis-retinal inside rhodopsin, activating a G-protein cascade (transducin → PDE6) that hydrolyzes cGMP, closes CNG cation channels, and hyperpolarizes the rod from about -40 mV to -70 mV. Unusually, light makes the cell signal LESS — vertebrate photoreceptors are depolarized in the dark and respond to light by switching off their glutamate release. The cascade amplifies a single photon by roughly 100,000-fold, letting a dark-adapted rod reliably report one quantum of light.
- Trigger1 photon → 11-cis-retinal isomerizes
- Isomerization time~200 femtoseconds (QY ≈ 0.65)
- Second messengercGMP (falls when light hits)
- Voltage change-40 mV (dark) → -70 mV (light)
- Cascade gain~100,000× per photon
- Rods : Cones~92 M : ~4.6 M per retina
Interactive visualization
Press play, or step through manually. The visualization is yours to drive — try it before reading on.
Watch the 60-second explainer
A condensed visual walkthrough — narrated, captioned, under a minute.
The strangest signal in your body: light reported as darkness
Here is the counter-intuitive heart of vision. In the dark, a rod cell is busy. A steady inward current of Na+ and Ca2+ — the "dark current" — flows into its light-sensitive outer segment, holding the cell at a relatively depolarized -40 mV and making it spill the neurotransmitter glutamate continuously onto the next neuron. Then a photon arrives. The cell does less: the current shuts off, the membrane hyperpolarizes toward -70 mV, and glutamate release drops. Light is signaled by a cell going quiet. That inverted logic — the opposite of almost every other sensory receptor — is phototransduction.
Phototransduction is the biochemical chain that connects a single quantum of light to that voltage change. It is a textbook example of a G-protein-coupled receptor (GPCR) cascade, and it is the fastest and most amplified one known. The whole apparatus is packed into the outer segment of a rod or cone: a stack of about 1,000 flattened membrane discs in a rod, each disc studded with so much rhodopsin that the protein makes up roughly half the disc membrane's mass — on the order of 100 million rhodopsin molecules per rod. Nature built a structure whose only job is to catch photons and start this cascade.
The cascade, step by step
Run through one photon's journey from absorption to a closed channel:
- Absorption and isomerization. A photon is absorbed by 11-cis-retinal, the chromophore covalently bound inside rhodopsin via a protonated Schiff base to Lysine 296. The only thing the photon does is twist one double bond, flipping retinal from its bent 11-cis shape to the straight all-trans shape. This happens in about 200 femtoseconds with a quantum yield near 0.65 — one of the fastest photoreactions in biology.
- Receptor activation. The straightened retinal no longer fits the binding pocket. The strain drives rhodopsin through intermediates (bathorhodopsin → lumirhodopsin → metarhodopsin I) to the active state metarhodopsin II (Meta II, R*), which is a fully activated GPCR. R* stays catalytically active for roughly 50-100 ms.
- First amplification — transducin. R* acts as a guanine-nucleotide exchange factor for transducin (Gt), the rod's G protein. Each contact swaps GDP for GTP on transducin's α subunit, which then dissociates. One R* activates several hundred transducins before it is switched off — gain factor of a few hundred.
- Effector activation — PDE6. Each transducin-α·GTP binds and removes the inhibitory γ subunits of cGMP phosphodiesterase 6 (PDE6), unleashing its catalytic core.
- Second amplification — cGMP destruction. Active PDE6 hydrolyzes cyclic GMP (cGMP) to 5'-GMP at thousands of molecules per second. Cytoplasmic cGMP plummets — the second messenger falls instead of rising.
- Channel closure. In the dark, cGMP bound to cyclic-nucleotide-gated (CNG) channels held them open. As cGMP drops, these channels close cooperatively (they need about three cGMP bound to open), cutting off the inward Na+/Ca2+ dark current.
- Hyperpolarization. With the inward current gone, the unopposed K+ leak pulls the membrane from -40 mV toward -70 mV. This is the electrical "light response."
- Synaptic readout. Hyperpolarization closes voltage-gated Ca2+ channels at the synaptic terminal, so tonic glutamate release onto bipolar cells falls. The visual system reads the decrease in glutamate as light.
The two catalytic steps multiply: one R* makes ~hundreds of transducins, and each PDE6 destroys ~thousands of cGMPs. Their product is an overall gain near 100,000, which is exactly why a single absorbed photon produces a current change a rod can report above its own noise.
The molecular cast
- Rhodopsin (opsin + 11-cis-retinal). The receptor; a 7-transmembrane GPCR. Peak absorption ~498 nm. About 108 copies per rod. Cones use one of three cone opsins (S/M/L).
- 11-cis-retinal. The vitamin-A-derived chromophore. The single moving part — its isomerization is the entire light-sensing event.
- Transducin (Gt). The heterotrimeric G protein (α/β/γ) that couples R* to PDE6. The amplifying relay.
- PDE6. The effector enzyme that destroys cGMP. Held off by inhibitory γ subunits until transducin-α removes them.
- cGMP. The diffusible second messenger that gates the channels. Made by guanylate cyclase, destroyed by PDE6.
- CNG channels (CNGA1/CNGB1 in rods). The cation channels that carry the dark current. Open with cGMP bound; conduct Na+ and Ca2+.
- Recovery proteins. Rhodopsin kinase (GRK1) and arrestin shut off R*; RGS9-1 accelerates transducin GTP hydrolysis; guanylate cyclase + GCAPs rebuild cGMP under Ca2+ control; the Na+/Ca2+,K+ exchanger (NCKX) extrudes Ca2+.
Rods vs cones
| Property | Rods | Cones |
|---|---|---|
| Pigment | Rhodopsin (peak ~498 nm) | Cone opsins: S ~420, M ~534, L ~564 nm |
| Number per human retina | ~92 million | ~4.6 million |
| Sensitivity | Single-photon detection | ~100× less sensitive |
| Vision type | Scotopic (dim light), monochrome | Photopic (bright light), color |
| Response speed | Slow (~200-300 ms to peak) | Fast (recovers for >60 Hz flicker) |
| Saturation | Saturates in daylight | Does not saturate |
| Spatial distribution | Peripheral retina, absent in fovea | Dense in fovea (acuity) |
| Recovery kinetics | Slower Meta II / transducin shutoff | Faster shutoff & cGMP resynthesis |
The numbers that make it work
Phototransduction is a quantitative marvel, and the figures are worth pinning down:
- Isomerization: ~200 fs. Retinal twists faster than almost any biological event, with a quantum yield of ~0.65 — about two of every three absorbed photons trigger a response.
- Amplification: ~105. One R* → several hundred active transducins; each PDE6 → thousands of cGMPs hydrolyzed per second. The product closes hundreds of CNG channels.
- Single-photon response: ~1 pA, ~1 mV, lasting hundreds of ms. Small but reliably above the rod's intrinsic dark noise — rhodopsin spontaneously isomerizes only about once every ~1,000 years per molecule, keeping false alarms rare.
- Dark current: ~20-50 pA of inward Na+/Ca2+ flowing continuously in the dark, which a bright flash can shut off almost completely.
- Voltage swing: -40 mV (dark) → ~-70 mV (bright light). Note photoreceptors do not fire action potentials; they use graded, analog hyperpolarization.
- Dynamic range: ~1010. Between a single photon at night and noon sunlight, the eye spans roughly ten orders of magnitude of intensity, handled largely by Ca2+-driven light adaptation in the photoreceptors plus pupil and neural mechanisms.
- Disc renewal: ~10% per day. The outer segment continuously sheds the oldest discs (phagocytosed by the retinal pigment epithelium) and builds new ones at the base — a rod's entire outer segment is rebuilt in about 10 days.
- Human absolute threshold: ~5-14 photons. Hecht, Shlaer and Pirenne (1942) showed a dark-adapted person can detect a flash delivering only a handful of absorbed photons across the retina.
Shutting off and adapting: the Ca²⁺ feedback loop
A switch that turns on but never off is useless. Recovery quenches every active component and rebuilds cGMP. Active rhodopsin (R*) is phosphorylated by rhodopsin kinase (GRK1) and then capped by arrestin, ending transducin activation. Transducin shuts itself off by hydrolyzing its bound GTP — a slow reaction that the RGS9-1 GAP complex speeds up by orders of magnitude, releasing PDE6's inhibitory subunits to re-quench the enzyme.
The elegant part is the calcium feedback. Because CNG channels carry Ca2+ as well as Na+, closing them in the light stops Ca2+ entry while the NCKX exchanger keeps pumping Ca2+ out — so intracellular Ca2+ falls. Low Ca2+ relieves GCAP-mediated inhibition of guanylate cyclase, which then synthesizes cGMP faster, reopening the channels and restoring the dark current. The same falling Ca2+ also speeds rhodopsin shutoff (via recoverin) and tweaks CNG-channel cGMP affinity (via calmodulin). This negative feedback is the molecular basis of light adaptation: it desensitizes the rod in steady light and lets vision keep working as background brightness changes by factors of millions, rather than the cell simply saturating.
Where it shows up: organisms, disease, and the visual cycle
- The visual cycle and vitamin A. After isomerization, all-trans-retinal is released, reduced to all-trans-retinol (vitamin A), shuttled to the retinal pigment epithelium, re-isomerized back to 11-cis by the enzyme RPE65, and returned to rebuild fresh rhodopsin. Dietary vitamin A deficiency starves this cycle and causes night blindness (nyctalopia) — historically treated with cod liver oil and still a leading cause of preventable childhood blindness worldwide.
- Retinitis pigmentosa. Mutations in rhodopsin (RHO, e.g. the misfolding P23H allele) are the leading cause of autosomal dominant RP; mutations in PDE6 and CNG channel subunits also cause RP. Rods degenerate first (night and peripheral vision lost), then cones.
- Achromatopsia. Mutations in the cone CNG channel subunits CNGA3/CNGB3 destroy cone function, leaving total color blindness and severe light sensitivity.
- Leber congenital amaurosis and gene therapy. RPE65 mutations break the visual cycle and cause early blindness. Voretigene neparvovec (Luxturna), approved by the FDA in 2017, delivers a working RPE65 gene by AAV — the first in-vivo gene therapy for an inherited disease.
- Pharmacology. The same cascade explains a famous side effect: sildenafil (Viagra) weakly inhibits PDE6 as well as its target PDE5, which can cause transient blue-tinged vision at high doses.
- Beyond image-forming vision. A separate opsin, melanopsin in intrinsically photosensitive retinal ganglion cells, uses an invertebrate-style (Gq/PLC/TRP) cascade to set the circadian clock and pupil response — a reminder that "phototransduction" names a family of cascades, not one.
- Invertebrate contrast. Fly photoreceptors depolarize to light via a phospholipase-C / TRP-channel pathway — the opposite electrical sign from vertebrate rods, and the system in which the TRP channel was first discovered.
Common misconceptions
- "Light depolarizes the photoreceptor." Backwards for vertebrate rods and cones. They are depolarized in the dark and hyperpolarize to light. The current and glutamate release fall when light hits.
- "The second messenger rises with the stimulus." Also backwards. cGMP falls in light. It is one of the rare cascades where the stimulus destroys the second messenger rather than producing it.
- "Rods fire action potentials." No. Photoreceptors (and most retinal interneurons) use graded, analog membrane-potential changes. The first spikes in the visual pathway are generated by retinal ganglion cells.
- "One photon, one channel." The point of the cascade is amplification: a single photon closes hundreds of channels through ~105-fold gain. Without amplification a single photon would be invisible against noise.
- "Rhodopsin absorbs the photon and the protein does the chemistry." The chemistry is carried entirely by the bound retinal — the photon isomerizes one double bond. The opsin protein is the scaffold that turns that shape change into a GPCR signal.
- "Rods see color." Rods are monochromatic; a single pigment can't distinguish wavelength from intensity. Color requires comparing the outputs of the three cone types, which is why dim scenes look gray.
- "The cell is signaling continuously, so it must be energetically cheap to be quiet." The opposite — maintaining the dark current and pumping ions back makes photoreceptors among the most metabolically demanding cells in the body, and light (which shuts the current off) actually reduces their energy demand.
Frequently asked questions
Why do photoreceptors hyperpolarize in response to light instead of depolarizing?
Vertebrate rods and cones are unusual: they are depolarized in the dark and respond to light by hyperpolarizing. In darkness, cytoplasmic cGMP holds cyclic-nucleotide-gated (CNG) channels open, so a steady inward 'dark current' of Na+ and Ca2+ keeps the cell at about -40 mV and drives continuous glutamate release at the synapse. Light triggers the cascade that destroys cGMP, the CNG channels close, the inward current stops, and the K+ leak current pulls the membrane toward its equilibrium near -70 mV. So the signal for light is a reduction in current and in glutamate release — light is encoded as the cell going quiet. This inverted logic is a quirk of the cilium-derived photoreceptor design; invertebrate rhabdomeric photoreceptors, by contrast, depolarize to light using a different (phospholipase-C / TRP-channel) cascade.
How can a rod detect a single photon?
A rod can reliably report the absorption of a single photon because the cascade amplifies enormously. One activated rhodopsin (metarhodopsin II) stays catalytically active for roughly 50-100 ms and during that time activates several hundred transducin molecules. Each transducin alpha subunit switches on one PDE6, and each active PDE6 hydrolyzes cGMP at thousands of molecules per second. The two multiplicative steps give an overall gain near 100,000, so one photon closes hundreds of CNG channels and produces a measurable ~1 pA, ~1 mV blip lasting hundreds of milliseconds. Classic experiments by Hecht, Shlaer and Pirenne (1942) and later single-cell recordings by Baylor, Lamb and Yau (1979) showed that dark-adapted rods respond to single photons; humans can perceive a flash of only about 5-14 absorbed photons spread across the retina.
What is the role of retinal in vision?
Retinal is the light-absorbing chromophore (a vitamin A derivative) bound covalently inside the opsin protein. In the dark it sits in the bent 11-cis configuration, tucked into a pocket of rhodopsin via a protonated Schiff base to a lysine residue (Lys296 in human rod opsin). Absorbing a photon does just one thing: it isomerizes the 11-cis double bond to the straight all-trans form within about 200 femtoseconds — one of the fastest and most efficient photochemical reactions known, with a quantum yield of about 0.65. That shape change strains the protein, driving rhodopsin through a series of intermediates to the active metarhodopsin II state. Because retinal comes from dietary vitamin A, severe vitamin A deficiency causes night blindness (nyctalopia) — the rods literally run out of chromophore to rebuild rhodopsin.
What is the difference between rods and cones in phototransduction?
Rods and cones use the same basic cascade — opsin, transducin, PDE6, cGMP, CNG channels — but with different protein isoforms tuned for different jobs. Rods carry rhodopsin (peak sensitivity ~498 nm), are exquisitely sensitive (single-photon detection) but slow and saturate in daylight; they mediate scotopic (dim-light) vision and there are roughly 92 million per human retina. Cones carry one of three cone opsins (S ~420 nm, M ~534 nm, L ~564 nm), are about 100 times less sensitive, recover far faster (allowing flicker fusion above 60 Hz), do not saturate in bright light, and give color and high-acuity daytime (photopic) vision; there are roughly 4.6 million, concentrated in the fovea. Cones have faster cascade kinetics largely because they shut off active rhodopsin and transducin more quickly and regenerate cGMP faster.
How does a rod recover and reset after detecting light?
Recovery requires shutting off every active element and rebuilding cGMP. Active rhodopsin is quenched in two steps: rhodopsin kinase (GRK1) phosphorylates its C-terminus, and arrestin then caps it, blocking further transducin activation. Transducin is switched off when its intrinsic GTPase hydrolyzes the bound GTP, a step dramatically accelerated by the RGS9-1 complex, releasing PDE6. Crucially, the falling Ca2+ (Ca2+ no longer enters through the closed CNG channels but is still pumped out by an Na+/Ca2+,K+ exchanger) relieves Ca2+-dependent inhibition of guanylate cyclase via GCAPs, so the cyclase ramps up and rebuilds cGMP, reopening the CNG channels. This Ca2+ feedback is the heart of light adaptation: it lets the rod reset and adjusts its gain so it can keep responding across an enormous range of background light. The all-trans-retinal is also released, reduced, shuttled to the retinal pigment epithelium, re-isomerized to 11-cis (the visual cycle), and returned to rebuild fresh rhodopsin.
What diseases are caused by defects in phototransduction?
Many inherited retinal diseases trace to phototransduction genes. Mutations in rhodopsin (RHO) — including the classic P23H misfolding mutation — are the most common cause of autosomal dominant retinitis pigmentosa, a progressive loss of rod then cone photoreceptors. Mutations in the CNG channel subunits (CNGA1/CNGB1) and in PDE6 subunits also cause retinitis pigmentosa, while CNGA3/CNGB3 mutations cause achromatopsia (total color blindness with poor cone function). Defects in RPE65 — an enzyme of the visual cycle that regenerates 11-cis-retinal — cause Leber congenital amaurosis, the target of voretigene neparvovec (Luxturna), the first FDA-approved in-vivo gene therapy (2017). Congenital stationary night blindness can result from mutations affecting transducin or rhodopsin signaling that leave rods chronically over- or under-active, and vitamin A deficiency produces an acquired, reversible night blindness by starving the cells of chromophore.